EFFICACY OF DIFFERENT INFECTIOUS BURSAL DISEASE VACCINES ADMINISTERED IN THE HATCHERY AGAINST A VERY VIRULENT IBDV CHALLENGE IN BROILER CHICKENS
The aim of this study was to evaluate the protective efficacy of a combination of a next-generation immune complex vaccine (GUMBOHATCH®) with recombinant HVT-ND vaccines compared to double-insert recombinant HVT-IBD+ND vaccines against a challenge with a very virulent IBDV (vvIBDV).
The study was also intended to assess whether the administration of GUMBOHATCH® interferes with the immune response produced by recombinant HVT-ND vaccines in broiler chickens.
EFFICACY OF DIFFERENT INFECTIOUS BURSAL DISEASE VACCINES AGAINST THE CURRENT IBDV CIRCULATING STRAINS IN THE BENELUX AREA
To assess the extent of the reassortant’s spread, HIPRA conducted a comprehensive screening of broiler farms in the Benelux region.
EFFICACY OF DIFFERENT VACCINATION PROGRAMMES INCLUDING IMMUNE COMPLEX IBD VACCINES AGAINST VERY VIRULENT IBDV CHALLENGE IN BROILER CHICKENS
The aim of this trial was to determine the protective efficacy of GUMBOHATCH® vs standard-formulated immune complex vaccines against a challenge infection with a very virulent IBDV (vvIBDV) strain in broiler chickens.
PREVALENCE OF THE NEW IBDV STRAIN UK2019 IN SLOW-GROWING BROILERS IN THE NETHERLANDS
This study was carried out with the aim of having an indication of the spread of the UK2019 strain in the Netherlands and to investigate whether there is a correlation between its appearance and the type of vaccine used.
EVALUATION OF THE STABILITY AND REPLICATION OF MAREK’S DISEASE VACCINES WHEN APPLIED TOGETHER WITH A NEXT-GENERATION IBD IMMUNE COMPLEX VACCINE
The aim of this study was to assess whether the administration of a next generation IBD immune complex vaccine (GUMBOHATCH®) interferes with MD vaccine viability and replication in birds when they are combined.
EVALUATION OF THE PHYLOGENETIC RELATEDNESS OF 106 GENOGROUP 2 IBDV FROM SEVEN DIFFERENT COUNTRIES IN SOUTH AMERICA, EUROPE AND ASIA
A broad analysis of the characterization and circulation of G2 type viruses in different countries is necessary for a better understanding of the virus evolution and implementation of proper measures to improve the control of the disease worldwide.
EFFICACY OF GUMBOHATCH® AGAINST AN EXPERIMENTAL CHALLENGE WITH INFECTIOUS BURSAL DISEASE VIRUS STRAIN UK2019 IN BROILERS
An efficacy trial was performed in order to assess whether GUMBOHATCH®, an immune complex vaccine
against IBDV, would protect chickens from a UK2019 challenge.
DETERMINATION OF THE BREAKTHROUGH ELISA TITRE OF LIVE IBD IMMUNE COMPLEX VACCINE STRAINS
The objective of this study was to determine the breakthrough titre of strain 1052, the vaccinal strain of GUMBOHATCH®.
COMPARISON OF THE SAFETY AND IMMUNOGENICITY OF DIFFERENT IBD VACCINE TECHNOLOGIES IN BROILER CHICKENS
The aim of this trial was to evaluate the safety and the immune response produced by GUMBOHATCH® in comparison to different IBD vaccine technologies when administered in commercial broiler chickens with a high MDA levels.
COMPARISON BETWEEN GUMBOHATCH® AND A STANDARD-FORMULATED IMMUNE COMPLEX VACCINE ON A BROILER FARM IN IRAN
This study was performed with the aim of evaluating the safety and efficacy of GUMBOHATCH® when administered via the subcutaneous route in broilers compared to a standard-formulated immune complex vaccine in Iran, Gilan Province.
BENEFITS OF A NEXT-GENERATION IMMUNE COMPLEX VACCINE AGAINST IBD IN SOUTH AMERICA, FIRST RESULTS IN BRAZIL
The objective of this study was to evaluate the efficacy of GUMBOHATCH® where variant Gumboro virus is circulating on Brazilian farms where vaccination programmes are based on the administration of standard formulation immune complex vaccines.
SAFETY OF AN IMMUNE COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE WHEN APPLIED SUBCUTANEOUSLY IN SLOW-GROWING BROILER TYPE CHICKENS UNDER FIELD CONDITIONS
The objective of this study was to test the safety of GUMBOHATCH® when applied subcutaneously in slow-growing chickens under field conditions.
STUDY OF THE EFFICACY OF GUMBOHATCH® (LIVE VACCINE AGAINST INFECTIOUS BURSAL DISEASE) IN BROILER CHICKEN
The objective of this tria! was to assess the efficacy of GUMBOHATCH” in broiler chickens a-fter an experimental challenge with a high dese of a very virulent IBD virus (wlBDV) strain.
EVALUATION UNDER FIELD CONDITIONS OF THE SAFETY AND THE EFFICACY OF GUMBOHATCH® VACCINE ADMINISTERED IN OVO AGAINST INFECTIOUS BURSAL DISEASE IN EUROPE
The present multicenter, positive-controlled and blind dinical trial was performed with the aim to evaluate its safety and efficacywhen administered in ovo underfield conditions in Europe.
EVALUATION UNDER FIELD CONDITIONS OF THE SAFETY AND THE EFFICACY OF GUMBOHATCH® VACCINE ADMINISTERED BY SUBCUTANEOUS ROUTE AGAINST INFECTIOUS BURSAL DISEASE
The present multicenter, positive-controlled and blind clinical tria[ was performed with the aim to evaluate its safety and efficacywhen administered by subcutaneous route underfield conditions.
EVALUATION UNDER FIELD CONDITIONS OF THE SAFETV AND THE EFFICACY OF GUMBOHATCH® VACCINE ADMINISTERED IN OVO AGAINST INFECTIOUS BURSAL DISEASE IN BRAZIL
The present multicenter, positive-controlled and blind clinical trial was performed with the aim to evaluate its safety and efficacy when administered in ovo under field conditions in Brazil.
SAFETY OF SUBCUTANEOUS ADMINISTRATION OF A NEW IMMUNE COMPLEX BASED VACCINE AGAINST INFECTIOUS BURSAL DISEASE IN SLOW-GROWING BROILER TYPE CHICKENS
The objective of this study was to test experimentally the safety of a new immune complex based vaccine against IBDV when administered subcutaneously in slow-growing broilers in experimental conditions.
EFFICACY OF A NEW IMMUNE-COMPLEX IBDV VACCINE AGAINST EXPERIMENTAL INFECTION WITH THE DD1 STRAIN IN BROILER CHICKEN
The objective of this trial was to assess the efficacy of GUMBOHATCH® in broiler chickens after an experimental challenge with the DDl strain.
EVALUATION OF THE SAFETY AND EFFICACY OF GUMBOHATCH® VACCINE ADMINISTERED IN OVO ON A BELGIAN FARM COMPARED TO AN INTERMEDIATE PLUS DRINKING WATER VACCINE
The present field trial was performed to compare the efficacy and safety og GUMBOHATCH® immune-complex vaccine against Infectious Bursal Disease (IBD) with an intermediate plus drinking water vaccine.